FI95380B - Förfarande för framställning av terapeutiskt användbara heterocykliska föreningar - Google Patents
Förfarande för framställning av terapeutiskt användbara heterocykliska föreningar Download PDFInfo
- Publication number
- FI95380B FI95380B FI914058A FI914058A FI95380B FI 95380 B FI95380 B FI 95380B FI 914058 A FI914058 A FI 914058A FI 914058 A FI914058 A FI 914058A FI 95380 B FI95380 B FI 95380B
- Authority
- FI
- Finland
- Prior art keywords
- formula
- pyridyl
- alkyl
- amine
- salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Indole Compounds (AREA)
Claims (2)
1. Förfarande för framställning av terapeutiskt användbara heterocykliska föreningar med formeln I 5 3. p-A ! /Z2~hr2 Ar, N N 1 ^zrw 10 jossa A är 0 eller S; B är C eller N; Z3 är Cx_4-alkylen eller fenylen; Z2 är C^-alkylen;
15 W är NRjR2, väri Rx är H eller C1.4-alkyl och R2 är H, Cj_4-alkyl, fenyl, C0NQxQ2 eller CSNQXQ2, väri Qx och Q2 självständigt är H eller C^-alkyl; S02Q3 eller C0Q3, väri Q3 är C1.4-alkyl, COOQ4; väri Q4 är C^-alkyl eller bensyl, eller Rx och R2 tillsammans med N bildar en mättad hetero- 20 cyklisk morfolin-, pyrrolidin-, piperidin-, piperazin-eller 4-(C1.3 )-alkylpiperazingrupp, eller W är en N-oxid av aminen NRXR2, eller W är C^-alkoxi eller C^-tioalkoxi, C0NQ1Q2, pyridyl, imidazolyl eller C00Q5, väri Q5 är Cj.,*-alkyl;
25 R3 är icke närvarande dä B är N, eller är H, C^- alkyl eller halogen dä B är C; Arx är fenyl, som valfritt är substituerad med en eller flera grupper valda bland halogen, C1.4-alkyl, C1.4-alkoxi, hydroxi, karboxi, C00Q6, väri Q6 är C1.4-alkyl; kar- 30 bamoyl, cyano, cyklohexyl, amino, acetamido, nitro, tri-fluormetyl, eller Arx är tienyl, som kan vara substituerad med tvä metylgrupper, indolyl, som eventuellt är N-metyl-substituerad, eller Arx är naftyl, bensyl eller cyklohexyl, eller Arx och R3 tillsammans bildar en grupp orv 78 95380 sälunda, att kolet i fenylen är bundet tili 4-position i den heterocykliska gruppen och att q är 2 - 4, Ar2 är kino-lyl, indolyl eller pyridyl, som valfritt substituerats med C1.3-alkyl; samt salter av dessa föreningar med syror eller 5 baser, kännetecknat därav, att man (a) utför en substitutionsreaktion mellan primära aminer H2N-Z1W eller H2N-Z2Ar2 eller en sekundär amin med formeln IV Ar2z2v 10 ^NH och en heterocyklisk grupp med formeln V W-Zj/ R3>vr''A>|j^x , väri X är halogen eller sulfonat, var- A -N 15 1 vid reaktionen, dä aminen är primär, efterföljs av substi-tuering av den sekundära aminen, vilken erhällits genom reaktion med antingen W-ZXY eller Ar2-Z2-Y, där Y är halogen eller sulfonat och varvid A, B, R3, Arx, Ar2, Zlf Z2 och W 20 är säsom definierats i formeln I, med undantag av att R3 = halogen, eller Arx, Ar2 och W är ekvivalenta med grupperna i formeln I, i vilka de reaktionskapabla grupperna är skyddade, i vilket fall skyddsgrupperna avlägsnas efter substitueringen, eller 25 b) för framställning av sädana föreningar med for meln I, väri A är S och B är C, 1. kondenserar en tiourea med formeln VI Ar2_z2N^ / N - C - NH9 30. n 2 W-Zj/ s • med en α-halogenketon med formeln VII Arx - CO - CHX - R3 35 väri Arx, Ar2, Zlr Z2, R3 och W är säsom definierats i formeln I med undantag av att R3 = halogen, eller Ara, Ar2 och Il in t nm i s t« 1 79 95380 W betecknar ekvivalenta grupper, där de reaktionskapabla grupperna är skyddade, i vilket fall skyddsgrupperna av-lägsnas efter kondenseringen, eller 2. kondenserar en amin med formeln IV 5 *r2-Z2 NH W-Z^ med en α-tiocyanatoketon med formeln VIII 10 Αγ,-CO-CH-R, SCN 15 väri Arx, Ar2, Zlf Z2, R3 och W är säsom definierats i formeln I med undantag av att R3 = halogen, eller Ar3, Ar2 och W betecknar ekvivalenta grupper, där de reaktionskapabla grupperna är skyddade, i vilket fall skyddsgrupperna avlägsnas efter kondenseringen, eller 20 c) för framställning av sädana föreningar med for meln I, där A är S eller 0, B är C och R3 är halogen, utför halogenering av motsvarande förening med formeln I, i vil-ken R3 är H och vilken erhällits med nägot av förfarandena a), bl) och b2) genom reaktion med halogen, eller 25 d) för framställning av sädana föreningar med for- • mein I, där W är NR3R2, där R2 valts bland CONQ^, CSNQjQj eller S02Q3, där Qlf Q2 och Q3, har i patentkravet 1 angivna betydelser, omsätter motsvarande förening, i vilken R2 är H och vilken erhällits med nägot av förfarandena a), bl) 30 och b2), med ett reaktivt derivat av R2, e) varefter föreningarna, som framställts med för-farandena a) - d), eventuellt omvandlas tili salter därav.
2. Förfarande enligt patentkrav 1, känne-t e c k n a t därav, att man framställer 2-(N-[2-N',N'-35 dimetylaminoetyl]-N-[3-pyridylmetyl] )amino-4-(2,4,6-tri-isopropylfenyl)tiazol.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8917491A FR2656610B1 (fr) | 1989-12-29 | 1989-12-29 | Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique. |
| FR8917491 | 1989-12-29 | ||
| PCT/FR1990/000970 WO1991009857A1 (fr) | 1989-12-29 | 1990-12-28 | Derives heterocycliques, leur procede de preparation et leur application therapeutique |
| FR9000970 | 1990-12-28 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI914058A0 FI914058A0 (sv) | 1991-08-28 |
| FI95380B true FI95380B (sv) | 1995-10-13 |
| FI95380C FI95380C (sv) | 1996-01-25 |
Family
ID=9389177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI914058A FI95380C (sv) | 1989-12-29 | 1991-08-28 | Förfarande för framställning av terapeutiskt användbara heterocykliska föreningar |
Country Status (31)
| Country | Link |
|---|---|
| US (5) | US5470855A (sv) |
| EP (1) | EP0462264B1 (sv) |
| JP (1) | JP2758077B2 (sv) |
| KR (1) | KR0159517B1 (sv) |
| CN (1) | CN1028757C (sv) |
| AT (1) | ATE119160T1 (sv) |
| AU (1) | AU627103B2 (sv) |
| BR (1) | BR1100202A (sv) |
| CA (1) | CA2046883C (sv) |
| CZ (1) | CZ280803B6 (sv) |
| DE (1) | DE69017443T2 (sv) |
| DK (1) | DK0462264T3 (sv) |
| ES (1) | ES2069276T3 (sv) |
| FI (1) | FI95380C (sv) |
| FR (1) | FR2656610B1 (sv) |
| HK (1) | HK1000011A1 (sv) |
| HU (2) | HU213230B (sv) |
| IE (1) | IE67322B1 (sv) |
| IL (1) | IL96811A (sv) |
| LV (1) | LV5803B4 (sv) |
| MX (1) | MX9203019A (sv) |
| NO (1) | NO179975C (sv) |
| NZ (1) | NZ236678A (sv) |
| PL (1) | PL167101B1 (sv) |
| PT (1) | PT96368B (sv) |
| RU (1) | RU2049784C1 (sv) |
| SK (1) | SK278810B6 (sv) |
| TW (1) | TW215921B (sv) |
| UA (1) | UA35546C2 (sv) |
| WO (1) | WO1991009857A1 (sv) |
| ZA (1) | ZA9010447B (sv) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9127304D0 (en) * | 1991-12-23 | 1992-02-19 | Boots Co Plc | Therapeutic agents |
| FR2692893B1 (fr) * | 1992-06-24 | 1994-09-02 | Sanofi Elf | Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. |
| GB9312893D0 (en) * | 1993-06-22 | 1993-08-04 | Boots Co Plc | Therapeutic agents |
| FR2714059B1 (fr) * | 1993-12-21 | 1996-03-08 | Sanofi Elf | Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. |
| FR2728901B1 (fr) * | 1994-12-28 | 1997-03-28 | Sanofi Sa | Derives de phenyl-4-thiazoles substitues, procede pour leur preparation et compositions pharmaceutiques les contenant |
| US5795905A (en) * | 1995-06-06 | 1998-08-18 | Neurocrine Biosciences, Inc. | CRF receptor antagonists and methods relating thereto |
| FR2735777B1 (fr) * | 1995-06-21 | 1997-09-12 | Sanofi Sa | Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant |
| US6288091B1 (en) | 1995-12-29 | 2001-09-11 | Boehringer Ingelheim Ltd. | Antiherpes virus compounds and methods for their preparation and use |
| DK0871619T3 (da) * | 1995-12-29 | 2003-03-03 | Boehringer Ingelheim Pharma | Phenylthiazolderivater med antiherpesvirusegenskaber |
| ZA9756B (en) * | 1996-01-16 | 1997-07-17 | Warner Lambert Co | Process for preparing 4,6-disubstituted pyrido[3,4-d]-pyrimidines |
| FR2754258B1 (fr) * | 1996-10-08 | 1998-12-31 | Sanofi Sa | Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant |
| US6057340A (en) * | 1998-02-03 | 2000-05-02 | American Home Products Corporation | Oxazole derivatives as serotonin-1A receptor agonists |
| FR2776925B3 (fr) * | 1998-04-07 | 2000-05-26 | Sanofi Sa | Utilisation de derives d'aminothiazole pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation |
| US6242448B1 (en) | 1998-12-17 | 2001-06-05 | American Home Products Corporation | Trisubstituted-oxazole derivatives as serotonin ligands |
| US6699866B2 (en) | 2001-04-17 | 2004-03-02 | Sepracor Inc. | Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof |
| US6670071B2 (en) * | 2002-01-15 | 2003-12-30 | Quallion Llc | Electric storage battery construction and method of manufacture |
| CA2562075C (en) * | 2004-04-20 | 2012-08-14 | Transtech Pharma, Inc. | Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators |
| GEP20115241B (en) | 2006-10-19 | 2011-06-10 | Takeda Pharmaceutical | Indole compound |
| TWI443090B (zh) | 2007-05-25 | 2014-07-01 | Abbvie Deutschland | 作為代謝性麩胺酸受體２（ｍｇｌｕ２ 受體）之正向調節劑之雜環化合物 |
| CA2731442A1 (en) * | 2008-08-29 | 2010-03-04 | Transtech Pharma, Inc. | Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE471555A (sv) * | 1943-06-22 | |||
| DE3486009T2 (de) * | 1983-09-09 | 1993-04-15 | Takeda Chemical Industries Ltd | 5-pyridyl-1,3-thiazol-derivate, ihre herstellung und anwendung. |
| FR2612187B1 (fr) * | 1987-03-12 | 1989-07-21 | Sanofi Sa | Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant |
-
1989
- 1989-12-29 FR FR8917491A patent/FR2656610B1/fr not_active Expired - Fee Related
-
1990
- 1990-12-14 CZ CS906277A patent/CZ280803B6/cs not_active IP Right Cessation
- 1990-12-14 SK SK6277-90A patent/SK278810B6/sk unknown
- 1990-12-26 TW TW079110854A patent/TW215921B/zh active
- 1990-12-27 IL IL9681190A patent/IL96811A/en not_active IP Right Cessation
- 1990-12-27 PT PT96368A patent/PT96368B/pt not_active IP Right Cessation
- 1990-12-28 ZA ZA9010447A patent/ZA9010447B/xx unknown
- 1990-12-28 KR KR1019910701025A patent/KR0159517B1/ko not_active IP Right Cessation
- 1990-12-28 ES ES91902715T patent/ES2069276T3/es not_active Expired - Lifetime
- 1990-12-28 PL PL90292008A patent/PL167101B1/pl not_active IP Right Cessation
- 1990-12-28 CA CA002046883A patent/CA2046883C/en not_active Expired - Fee Related
- 1990-12-28 AU AU70555/91A patent/AU627103B2/en not_active Ceased
- 1990-12-28 RU SU5001534/04A patent/RU2049784C1/ru not_active IP Right Cessation
- 1990-12-28 EP EP91902715A patent/EP0462264B1/fr not_active Expired - Lifetime
- 1990-12-28 IE IE472190A patent/IE67322B1/en not_active IP Right Cessation
- 1990-12-28 HU HU912819A patent/HU213230B/hu not_active IP Right Cessation
- 1990-12-28 DK DK91902715.1T patent/DK0462264T3/da active
- 1990-12-28 UA UA5001534A patent/UA35546C2/uk unknown
- 1990-12-28 AT AT91902715T patent/ATE119160T1/de not_active IP Right Cessation
- 1990-12-28 DE DE69017443T patent/DE69017443T2/de not_active Expired - Fee Related
- 1990-12-28 WO PCT/FR1990/000970 patent/WO1991009857A1/fr active IP Right Grant
- 1990-12-28 JP JP3502549A patent/JP2758077B2/ja not_active Expired - Fee Related
- 1990-12-28 HU HU912819A patent/HUT61761A/hu unknown
- 1990-12-29 CN CN90110167A patent/CN1028757C/zh not_active Expired - Fee Related
-
1991
- 1991-01-04 NZ NZ236678A patent/NZ236678A/en unknown
- 1991-08-28 FI FI914058A patent/FI95380C/sv active
- 1991-08-28 NO NO913378A patent/NO179975C/no unknown
-
1992
- 1992-06-19 MX MX9203019A patent/MX9203019A/es unknown
-
1993
- 1993-08-25 US US08/111,732 patent/US5470855A/en not_active Expired - Lifetime
-
1995
- 1995-08-04 US US08/511,468 patent/US5780468A/en not_active Expired - Fee Related
-
1996
- 1996-07-18 LV LV960269A patent/LV5803B4/xx unknown
-
1997
- 1997-04-01 BR BR1100202-6A patent/BR1100202A/pt active IP Right Grant
- 1997-07-08 HK HK97101518A patent/HK1000011A1/fr not_active IP Right Cessation
-
1998
- 1998-05-20 US US09/081,782 patent/US6057318A/en not_active Expired - Fee Related
- 1998-05-20 US US09/081,669 patent/US5891893A/en not_active Expired - Fee Related
- 1998-05-20 US US09/081,783 patent/US5891894A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI95380B (sv) | Förfarande för framställning av terapeutiskt användbara heterocykliska föreningar | |
| FI73670C (sv) | Förfarande för framställning av nya terapeutiskt användbara fenoxialky l-1,2,4-triazol-3-on derivat. | |
| Turner et al. | Antihypertensive thiadiazoles. 2. Vasodilator activity of some 2-aryl-5-guanidino-1, 3, 4-thiadiazoles | |
| FI81097B (fi) | Foerfarande foer framstaellning av nya terapeutiskt verksamma tiazolidindionderivat. | |
| JPS5916889A (ja) | ２↓−（４↓−ピリジル）↓−チアゾ−ル誘導体 | |
| GB2184447A (en) | A substituted triazolone | |
| AU2001266345B2 (en) | Five-membered-ring compound | |
| HU220046B (hu) | Pirazolo-pirimidinon-származékok, az ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra | |
| EP0175363A2 (de) | 4, 5-Dihydro-3(2H)-pyridazinone, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| JPH0656809A (ja) | チアゾールの分枝状アルキルアミノ誘導体、製造方法および医薬組成物 | |
| FI76076C (sv) | Förfarande för framställning av farmakologiskt värdefulla heterocyklis ka föreningar | |
| US4098894A (en) | Triphenyl-1,2,3-triazolyl-(1)-methanes, and compositions and methods for combating fungi and bacteria employing them | |
| PL179032B1 (pl) | kwasu hydroksamowego oraz kompozycje farmaceutyczne zawierajace nowe pochodnekwasu hydroksamowego PL PL | |
| CA2045755A1 (en) | Thiazolidinecarboxylic acid amide derivatives having anti-allergic activity, their preparation and their use | |
| CS214841B2 (en) | Method of making the tetrahydrochinolines | |
| US4376788A (en) | Basic ethers of 4-hydroxy-benzophenones acting as beta-blocking agents | |
| IL28197A (en) | Piperazine derivatives and their manufacture | |
| JPS62242656A (ja) | 殺菌作用を有するシアノアセトアミド誘導体 | |
| Foks et al. | Full Text HTML | |
| Hassaneen et al. | REACTIONS OF N-(~-NITR~ OPHEN~)-C-(~-TH~ EN~)-FORMOHMRAZIDO~ | |
| JPH02152972A (ja) | １−（３−置換−２−フェニルプロピル）−１ｈ−１，２，４−トリアゾール誘導体 | |
| NZ205701A (en) | Substituted pyrimidone derivatives and pharmaceutical compositions | |
| CS203006B2 (cs) | Způsob výroby nových derivátů alkylendiaminu |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| PC | Transfer of assignment of patent |
Owner name: SANOFI-AVENTIS |